首页> 外文期刊>Open Journal of Modern Neurosurgery >Endoscopic Endonasal Surgery for Clinically Nonfunctioning Pituitary Adenomas
【24h】

Endoscopic Endonasal Surgery for Clinically Nonfunctioning Pituitary Adenomas

机译:临床无障碍垂体腺瘤的内窥镜型外肠手术

获取原文
       

摘要

Background: Clinically nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary macroadenomas, and represent approximately one-third of all pituitary adenomas. Patients often present with symptoms of mass effects, such as visual field defects, chronic headache, and hypopituitarism. Objective: The objective of this study was to retrospectively analyze the surgical results of 35 patients with non-functioning pituitary adenomas (NFPAs) operated by the endoscopic endonasal approach (EEA). Surgical outcomes including postoperative complications, recurrence and the postoperative visual and endocrine profile were assessed. Results: This retrospective study included 35 patients operated for clinically nonfunctioning pituitary adenomas (NFPAs) in Al Azhar university hospitals treated by endoscopic endonasal approach (EEA) in the last 6 years. 65.7% (n = 23) were male and 34.3 % (n = 12) were female. The mean age was 41.5 (range 18 - 65) years. The most common presenting symptoms were headache, with 60% of the patients having headache. Visual disturbances were the presenting symptom in 82.9% patients and endocrinological problems (panhypopituitarism) were present in 6 (17.1%) patients. The number of patients suffering from cranial nerve deficit was 2 (5.7%). Visual acuity and visual field improved in 23 (79.3%) of 29 patients. The rate of tumor recurrence/regrowth was higher in the case of giant adenomas and cavernous sinus invasion represent ed 11 patients (31.4%). Conclusions: Early endoscopic endonasal approach surgery of NFPAs and effective surgical decompression reduces morbidity. Visual deficit improves in two third of cases. NFPAs represent high rate of recurrence due to invasion or incomplete resection especially with giant adenomas. The recurrence rate with growth total resection (GTR) is lower than subtotal resection (STR).
机译:背景:临床上无搏动腺瘤(NFPA)是最常见的垂体腺瘤组,并且代表所有垂体腺瘤的约三分之一。患者通常存在质量效应的症状,如视野缺陷,慢性头痛和低钠术。目的:本研究的目的是回顾性地分析35例非功能性垂体腺瘤(NFPA)的手术结果通过内窥镜型 - 内蒙联方法(EEA)操作。评估外科结果,包括术后并发症,复发和术后视觉和内分泌剖面。 结果:该回顾性研究包括在过去6年内通过内镜型 - 嗜酸术(EEA)治疗的Al Azhar大学医院在临床无障碍垂体腺瘤(NFPA)的35名患者。 65.7%(n = 23)是男性,女性是女性的34.3%(n = 12)。平均年龄为41.5(范围18 - 65)年。最常见的呈现症状是头痛,60%的患者头疼。视觉紊乱是82.9%患者的症状和内分泌问题(胰蛋白酶学)中存在6例(17.1%)患者。患有颅神经缺陷的患者的数量为2(5.7%)。视力和视野在23例(79.3%)的29名患者中得到改善。在巨型腺瘤和海绵窦侵袭的情况下,肿瘤复发/再生的速率较高,代表ED 11患者(31.4%)。 结论:NFPA的早期内窥镜内镜前进性手术和有效外科减压降低了发病率。在三分之二的情况下,视觉赤字改善。由于侵袭或不完全切除,NFPA尤其代表高复发率,尤其是巨型腺瘤。具有生长总切除术(GTR)的复发率低于小畸切除(STR)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号